Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.
Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.
复制标题
DOI：
10.1016/j.jmb.2011.02.038
复制
发表时间：
2011-04-29
影响因子：
5.6
通讯作者：
Walter NG
中科院分区：
文献类型：
--
作者：
Rawlings RA;Krishnan V;Walter NG
RNA interference (RNAi) is a conserved gene regulatory mechanism employed by most eukaryotes as a key component of their innate immune response against viruses and retrotransposons. During viral infection, the RNase III-type endonuclease Dicer cleaves viral double-stranded RNA into small interfering RNAs (siRNAs), 21–24 nucleotides in length, and helps load them into the RNA-induced silencing complex (RISC) to guide cleavage of complementary viral RNA. As a countermeasure, many viruses have evolved viral RNA silencing suppressor (RSS) proteins that tightly, and presumably quantitatively, bind siRNAs to thwart RNAi-mediated degradation. Viral RSS proteins also act across kingdoms as potential immunosuppressors in gene therapeutic applications. Here we report fluorescence quenching and electrophoretic mobility shift assays that probe siRNA binding by the dimeric RSS p19 from Carnation Italian Ringspot Virus (CIRV), as well as by human Dicer and RISC assembly complexes. We find that the siRNA:p19 interaction is readily reversible, characterized by rapid binding ((1.69 ± 0.07)×108 M−1s−1) and marked dissociation (koff = 0.062 ± 0.002 s−1). We also observe that p19 efficiently competes with recombinant Dicer and inhibits formation of RISC-related assembly complexes found in human cell extract. Computational modeling based on these results provides evidence for the transient formation of a ternary complex between siRNA, human Dicer, and p19. An expanded model of RNA silencing indicates that multiple-turnover by reversible binding of siRNAs potentiates the efficiency of the suppressor protein. Our predictive model is expected to be applicable to the dosing of p19 as a silencing suppressor in viral gene therapy.
登录
查看更多内容
影响因子：
14.9
作者：
Bartlett DW;Davis ME
通讯作者：
Davis ME
影响因子：
3.7
作者：
Chu, M;Desvoyes, B;Scholthof, HB
通讯作者：
Scholthof, HB
影响因子：
4.5
作者：
Hoerter, John A. H.;Walter, Nils G.
通讯作者：
Walter, Nils G.
影响因子：
64.8
作者：
Grimm, Dirk;Streetz, Konrad L.;Kay, Mark A.
通讯作者：
Kay, Mark A.
影响因子：
12.4
作者：
Beer, Shelly;Bellovin, David I.;Grimm, Dirk
通讯作者：
Grimm, Dirk